Uterine sarcoma: steroid receptors and response to hormonal therapy
- PMID: 2258084
- DOI: 10.1016/0090-8258(90)90267-o
Uterine sarcoma: steroid receptors and response to hormonal therapy
Abstract
Seventy-three patients with uterine sarcomas were treated between 1976 and 1987. Steroid receptors were analyzed in 60 cases; 48% were estrogen receptor (ER) positive, and 30% progesterone receptor (PR) positive. Only 1 of 28 patients with residual or recurrent disease showed a response to hormonal therapy. Neither receptor status of the primary tumor nor use of adjuvant hormonal therapy affected survival.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials